D.A. Davidson & Co. Voyager Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$8.59 - $18.05 $115,965 - $243,675	-13,500 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$17.11 - $21.74 $200,991 - $255,379	-11,747 Reduced 46.53%	13,500 $255,000
Q2 2018 Aug 02, 2018	BUY	$16.76 - $23.92 $3,486 - $4,975	208 Added 0.83%	25,247 $493,000
Q1 2018 May 04, 2018	BUY	$16.16 - $31.31 $48,140 - $93,272	2,979 Added 13.5%	25,039 $470,000
Q4 2017 Feb 08, 2018	BUY	$12.26 - $25.88 $270,455 - $570,912	22,060	22,060 $366,000

131

34.9M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $215M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.